Cypress Capital Management (Wyoming)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,218
Closed -$1.36M 152
2024
Q3
$1.36M Sell
4,218
-68
-2% -$22.2K 1.47% 23
2024
Q2
$1.34M Sell
4,286
-287
-6% -$84.3K 1.43% 25
2024
Q1
$1.3M Sell
4,573
-24
-0.5% -$7.02K 1.39% 30
2023
Q4
$1.32M Sell
4,597
-242
-5% -$65.9K 1.45% 19
2023
Q3
$1.3M Sell
4,839
-99
-2% -$24.7K 1.53% 24
2023
Q2
$1.1M Sell
4,938
-140
-3% -$32.5K 1.23% 25
2023
Q1
$1.23M Sell
5,078
-11
-0.2% -$2.7K 1.44% 22
2022
Q4
$1.34M Buy
5,089
+5,037
+9,687% +$1.35M 1.66% 21
2022
Q3
$12K Hold
52
0.02% 101
2022
Q2
$13K Hold
52
0.02% 103
2022
Q1
$13K Buy
+52
New +$11.9K 0.02% 111
2019
Q1
Sell
-236
Closed -$46K 276
2018
Q4
$46K Sell
236
-80
-25% -$15.6K 0.09% 131
2018
Q3
$66K Hold
316
0.07% 148
2018
Q2
$58K Buy
316
+181
+134% +$32K 0.06% 152
2018
Q1
$23K Hold
135
0.03% 189
2017
Q4
$23K Buy
135
+80
+145% +$14.2K 0.03% 196
2017
Q3
$10K Hold
55
0.01% 211
2017
Q2
$9.47K Hold
55
0.01% 207
2017
Q1
$9.02K Hold
55
0.01% 212
2016
Q4
$8.23K Hold
55
0.01% 213
2016
Q3
$9.18K Hold
55
0.01% 184
2016
Q2
$8.37K Hold
55
0.01% 177
2016
Q1
$8.25K Hold
55
0.01% 173
2015
Q4
$8.93K Hold
55
0.01% 187
2015
Q3
$7.61K Hold
55
0.01% 191
2015
Q2
$8.44K Hold
55
0.01% 215
2015
Q1
$8.79K Hold
55
0.01% 204
2014
Q4
$8.76K Buy
+55
New +$8.57K 0.01% 195

Other funds holding AMGN

Cypress Capital Management (Wyoming)'s AMGN Position: Q4 2024 in Review

Cypress Capital Management (Wyoming) sold out of Amgen (AMGN) in Q4 2024, closing a stake of 4,218 shares — an estimated $1.36M sold.

Cypress Capital Management (Wyoming) first reported a position in AMGN in Q4 2014 and held it in 28 quarters. The position peaked at $1.36M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Cypress Capital Management (Wyoming) reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 4,218 Amgen shares in Q4 2024, an estimated $1.36M.
  • Cypress Capital Management (Wyoming) first reported a position in Amgen in Q4 2014 and held it in 28 quarters.
  • Cypress Capital Management (Wyoming)'s Amgen position peaked at $1.36M in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q4 2024, filed 23 Jan 2025.